Baker Biotech Capital (GP), LLC Insider Trading $VPHM VIROPHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in VIROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,765,213 shares
Latest Transaction: May 13 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in VIROPHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | J | 0.00 | 522,800 | 0 | 1,765,213 | 2.3 M to 1.8 M (-22.85 %) |
| May 10 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.70 | 463,082 | 5,881,836 | 2,288,013 | 2.8 M to 2.3 M (-16.83 %) |
| May 10 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.46 | 97,940 | 1,220,176 | 2,751,095 | 2.8 M to 2.8 M (-3.44 %) |
| May 10 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.62 | 62,658 | 791,026 | 2,849,035 | 2.9 M to 2.8 M (-2.15 %) |
| May 10 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.65 | 224,106 | 2,834,381 | 2,911,693 | 3.1 M to 2.9 M (-7.15 %) |
| May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.78 | 134,727 | 1,721,286 | 3,135,799 | 3 M to 3.1 M (+4.49 %) |
| May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.76 | 263,216 | 3,358,557 | 3,001,072 | 2.7 M to 3 M (+9.61 %) |
| May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.98 | 225,068 | 2,921,518 | 2,737,856 | 2.5 M to 2.7 M (+8.96 %) |
| May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.03 | 618,993 | 8,066,036 | 2,512,788 | 1.9 M to 2.5 M (+32.69 %) |
| Oct 21 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | J | 2.74 | 4,107 | 11,253 | 2,208,355 | 2.2 M to 2.2 M (+0.19 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 8.14 | 1,927 | 15,678 | 2,204,248 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 8.67 | 1,326 | 11,491 | 2,202,321 | 2.2 M to 2.2 M (+0.06 %) |
| Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 8.69 | 18,792 | 163,349 | 2,200,995 | 2.2 M to 2.2 M (+0.86 %) |
| Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 8.95 | 27,828 | 249,013 | 2,182,203 | 2.2 M to 2.2 M (+1.29 %) |
| Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 8.76 | 40,716 | 356,538 | 2,154,375 | 2.1 M to 2.2 M (+1.93 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 7.63 | 78,599 | 599,773 | 2,113,659 | 2 M to 2.1 M (+3.86 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 7.43 | 137,894 | 1,025,104 | 2,035,060 | 1.9 M to 2 M (+7.27 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 7.27 | 110,315 | 802,475 | 1,897,166 | 1.8 M to 1.9 M (+6.17 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.44 | 39,213 | 605,374 | 1,786,851 | 1.8 M to 1.8 M (-2.15 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.45 | 1,361 | 21,026 | 1,826,064 | 1.8 M to 1.8 M (-0.07 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.43 | 6,479 | 99,994 | 1,827,425 | 1.8 M to 1.8 M (-0.35 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.54 | 7,230 | 112,366 | 1,833,904 | 1.8 M to 1.8 M (-0.39 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.44 | 15,315 | 236,465 | 1,841,134 | 1.9 M to 1.8 M (-0.82 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.30 | 89,856 | 1,374,994 | 1,856,449 | 1.9 M to 1.9 M (-4.62 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.32 | 40,616 | 622,347 | 1,946,305 | 2 M to 1.9 M (-2.04 %) |
Page: 1